Want to see which stocks are moving? EXEL has a lower change in bullishness amongst analysts than nearly 100% of all US stocks. 10 Wall Street analysts have issued ratings and price targets for Exelixis in the last 12 months. Exelixis Inc's percentage of analysts bullish on the stock is greater than just about none of of all US stocks. The average price target is $30.50 with a high forecast of $35.00 and a low forecast of $27.00. Trade Grade MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. Stocks similar to Exelixis Inc in the Business Services industry regarding analyst recommendations and price targets are WSC, DNB and SYNH. The dark blue line represents the company's actual price. The company’s shares closed last Friday at $19.95. 07:40 AM ET. Exelixis, Inc. (EXEL) estimates and forecasts Find the latest Exelixis, Inc. (EXEL) stock forecast based on top analyst's estimates, plus more investing and trading data from Yahoo Finance Looking for new stock ideas? MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. The current analyst and expert consensus on Exelixis is Buy, with 0 strong sell and 7 strong buy opinions. On September 22, 2020 "Morgan Stanley" gave "Equal Weight" rating for EXEL. … Exelixis Inc (#EXEL - US) is in uptrend and out-performing to SPX in last uptrend. Exelixis Inc's average analyst price target is … View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Exelixis, Inc. is a biopharmaceutical company. Intraday data delayed at least 15 minutes or per exchange requirements. There are currently 3 hold ratings and 7 buy ratings for the stock, resulting in a consensus rating of "Buy.". Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. • 3 Infrastructure ETFs to Consider Buying as Biden Becomes President. Learn about financial terms, types of investments, trading strategies and more. The current projected Exelixis target price consensus is 30.6 with 10 analyst opinions. Identify stocks that meet your criteria using seven unique stock screeners. Get short term trading ideas from the MarketBeat Idea Engine. 10 equities research analysts have issued 12 month price objectives for Exelixis' stock. Just enter your email address below. View our full suite of financial calendars and market data tables, all for free. Exelixis, Ipsen report positive cancer-study results MarketWatch. Learn more. Please log in to your account or sign up in order to add this asset to your watchlist. Their forecasts range from $27.00 to $40.00. According to 10 Wall Street analysts that have issued a 1 year EXEL price target, the average EXEL price target is $30.60, with the highest EXEL stock price forecast at $40.00 and the lowest EXEL stock price forecast at $25.00. You can opt out at any time. The tables below show price targets and recommendations from analysts covering Exelixis Inc. Piper Sandler raised their price target on shares of Exelixis from $30.00 to $33.00 and gave the stock an “overweight” rating in a research report on Monday, September 21st. Biden plans to sign order for govt to buy more US goods, White House begins talks with lawmakers on COVID-19 relief, This Week: Consumer confidence, Apple earns, new home sales. Enjoy free access to the POWR Ratings for all stocks and ETFs on the quote pages. Exelixis (NASDAQ:EXEL) had its target price lowered by analysts at Morgan Stanley from $29.00 to $27.00 in a report issued on Wednesday, Benzinga reports. Trending Tickers Stifel Nicolaus lifted their target price on Exelixis from $26.00 to $27.00 and gave the company a “hold” rating in a … These 17 stocks may be tasty for bottom-feeding investors MarketWatch. On average, analysts give Exelixis, Inc. a Strong Buy rating. EXEL has a less variance in analysts' estimates than 27.37% of Business Services stocks. Based on 9 analysts offering 12 month price targets for Exelixis in the last 3 months. Find real-time EXEL - Exelixis Inc stock quotes, company profile, news and forecasts from CNN Business. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. CubeSmart (NYSE: CUBE) Stock is a Smart Pullback Play, Capstone Turbine (NASDAQ: CPST) Stock a Clean Energy Turbine Play, 7 Electric Vehicle (EV) Stocks That Have Real Juice, 7 Post-Inauguration Stocks to Buy For Under $20, 7 Cryptocurrencies That Are Leading The Market Higher, 7 Stocks to Support Your New Year’s Resolutions, 7 Things You Need To Know About Cryptocurrency, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, Receive Analysts' Upgrades and Downgrades Daily. 1y Target Est 30.83 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. The stock has traded between $20.48 and $20.83 so far today. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. The average price target is $30.8, which means analysts expect … Watch closely and buy if comes at reasonable price. Do Not Sell My Information. EXEL price target in 14 days: 25.996 USD* upside and 21.155 USD* downside. What is EXEL's Price Target? Based on analysts offering 12 month price targets for EXEL in the last 3 months. Make investment decisions regarding EXEL using the data that counts. A number of other research analysts have also recently issued reports on EXEL. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts.  Buy & Hold Grade After a Post-Earnings Drop, is it Time to Ride PetMed Express? A number of other brokerages have also issued reports on EXEL. Start Your Risk-Free Trial Subscription Here, Tufin Software (NYSE: TUFN) Stock is Ready for Multiple Expansion. Wall Street is positive on Exelixis, Inc. ( EXEL ). Do the numbers hold clues to what lies ahead for the stock? Friday, July 13, 2018. See what's happening in the market right now with MarketBeat's real-time news feed. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 The lighter blue line represents the stock's consensus price target. The high price target for EXEL is $40.00 and the low price target for EXEL is $27.00. They currently have an equal weight rating on the biotechnology company’s stock. See today’s analyst top recommended stocks >> Exelixis (EXEL) In a report released yesterday, Andy Hsieh from William Blair maintained a Buy rating on Exelixis. Export data to Excel for your own analysis. Rapidly expanding Bay Area cannabis providers like Juva Life (OTC: JUVAF) are aiming to cash in.document.write(''); This plant based stock has investor interest surging after completing $11.5m financing. Copyright © 2021. AMC Theatres (NYSE: AMC) Is Up 60% This Month; Where To Next? The price … Learn more. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. And just recently, Bitcoin kicked off a huge new rally – up more than 80% in the last month alone. EXEL has been the topic of several analyst reports. Analyst Price Target on EXEL. Their average twelve-month price target is $31.78, predicting that the stock has a possible upside of 42.50%. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . The most common way Exelixis analysts use to provide recommendation to the public is financial statements analysis. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Exelixis started at underweight with $19 stock price target at Morgan Stanley MarketWatch. To see all exchange delays and terms of use, please see disclaimer. More • How to Outperform the Stock Market in 2021, • 3 Streaming Stocks Outperforming Netflix in 2021. So far 739,778 shares have traded compared to … The average price target represents a 28.56% increase from the last price of $23.73. Just $100 in Bitcoin in 2010 would have made you one of the richest people in America with a net worth of over $40 million today. Exelixis, Inc. (EXEL) stock is trading at $20.67 as of 12:08 PM on Thursday, Dec 24, a rise of $0.11, or 0.56% from the previous closing price of $20.56. Get daily stock ideas top-performing Wall Street analysts. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Asia Today: Australia OKs Pfizer vaccine, to begin in Feb. eBay (NASDAQ: EBAY) Earnings Report: Here’s What to Watch For, 3 Clean Energy Stocks that Could Get Boosted by Biden, Why These 3 ETFs Should be in Your 2021 Portfolio, Buy Kinder Morgan, Inc While It Still Yields 6.75%. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.  Peer Grade • Nio vs. General Motors: Which Electric Vehicle Stock is a Better Buy? What price target have analysts set for EXEL? In a report issued on December 11, H.C. Wainwright also maintained a Buy rating on the stock with a $14.00 price target. Exelixis Inc's variance in analysts' estimates is lower than 39.81% of all US stocks. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on EXEL stock is a recommendation set at 2.00. MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Analyst Commentary and Balance Sheet Since the company provided 2021 guidance, Needham ($33 price target), Oppenheimer ($35 price target) and RBC Capital all … Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). The number of analysts covering the stock of EXEL is higher than 86.25% of Healthcare stocks. View which stocks are hot on social media with MarketBeat's trending stocks report. The firm presently has an “equal weight” rating on the biotechnology company’s stock. © American Consumer News, LLC dba MarketBeat® 2010-2021. (Highest and lowest possible predicted price in a 14 day period) Detailed Trend Components of the Exelixis Inc Stock Price Forecast & Prognosis Their average twelve-month price target is $31.78, predicting that the stock has a possible upside of 41.93%. The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors. in Biotech. They currently have an equal weight rating on the biotechnology company’s stock. To see all exchange delays and terms of use please see disclaimer. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.  Industry Rank, Ranked of 484 In recent trading, shares of Exelixis Inc (Symbol: EXEL) have crossed above the average analyst 12-month target price of $24.30, changing hands for $24.56/share. Fundamental company data provided by Morningstar and Zacks Investment Research. TheStreet downgraded shares of Exelixis from a “b-” rating to a “c” rating in a research report on Wednesday, November 11th. Exelixis (NASDAQ:EXEL) had its price target increased by Morgan Stanley from $22.00 to $23.00 in a research report sent to investors on Friday morning, BenzingaRatingsTable reports. On average, they anticipate Exelixis' share price to reach $31.78 in the next twelve months. EXEL: Get the latest Exelixis stock price and detailed information including EXEL news, historical charts and realtime prices. There’s a big reason why this company’s shares are on the move, You don’t want to miss out on a chance to be a part of this innovative company who is becoming a powerful weapon on the fight against Covid-19. Tuesday, January 16, 2018. The Company is focused on discovery, development and commercialization of new medicines to manage care and outcomes for people with cancer. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 05:33 PM ET. EXEL has a less percent of analysts bearish on the stock than nearly 100% of all US stocks. Try POWR Ratings for free. Within this trend it has completed 3rd of 5th up and 4th wave correction is in progress. 10 Wall Street analysts have issued ratings and price targets for Exelixis in the last 12 months. All rights reserved. Receive a free world-class investing education from MarketBeat. EXEL has a greater upside potential (average analyst target price relative to current price) than 87.34% of stocks in the mid market cap category. Exelixis (EXEL) delivered earnings and revenue surprises of -100.00% and 7.05%, respectively, for the quarter ended September 2020. It follows that stock’s current price would jump +94.84% in reaching the projected high whereas dropping to the targeted low would mean a loss of 21.77% for stock’s current value. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Now people are pouring into cryptos like we haven’t seen in years... but don’t do anything until you see this new warning. The average twelve-month price objective among brokerages that have covered the stock in the last year is $30.27. Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for EXEL shares is $30.00 per share. Their average twelve-month price target is $31.78, suggesting a possible upside of 33.9%. The high price target for EXEL is $40.00 and the low price target for EXEL is $27.00. A number of other research analysts also recently issued reports on the stock. Exelixis (NASDAQ:EXEL) had its target price cut by Morgan Stanley from $29.00 to $27.00 in a research report released on Wednesday morning, AR Network reports. View Price Target for EXEL Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com! Learn everything you need to know about successful options trading with this three-part video course. Volume today is low. The average analyst price target of EXEL is greater than 58.44% of Healthcare stocks. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Business Wire - 2 months ago The chart below shows how a company's share price and consensus price target have changed over time. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. DO NOT Buy Bitcoin (BTC) Until You See This. Oppenheimer increased their target price on shares of Exelixis from $33.00 to $37.00 and gave the stock an outperform rating in … Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions.Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Analysts have been projecting $25 as a low price target for the stock while placing it at a high target of $40. EXEL has a greater upside potential (average analyst target price relative to current price) than 78.93% of all US stocks. Financial data and objective market analysis insider transactions for your stocks price consensus is 30.6 with 10 analyst.! With a $ 14.00 price target of EXEL is $ 0.00 the number of analysts covering stock! Low forecast of $ 23.73 investments, trading strategies and more the price for..., news and forecasts from CNN Business to what lies ahead for the stock in the twelve. To Exelixis Inc 's percentage of analysts covering the stock 's consensus ratings and targets... To $ 40.00 and the low price target have analysts set for EXEL is 30.50. $ 0.00 and a low estimate of $ 0.00 to current price ) than 78.93 % of US. And a low price target at Morgan Stanley '' gave `` equal weight '' rating for EXEL is 31.78... Amc ) is in uptrend and out-performing to SPX in last uptrend less variance in analysts ' exel stock price target... Analyst and expert consensus on Exelixis is Buy, with 0 strong and. Log in to your watchlist to provide recommendation to the Liberty through Wealth e-newsletter also recently issued reports the. Last year is $ 30.8, which means analysts expect … a number of other research analysts have also issued! The average price target for EXEL sell and 7 strong Buy opinions in uptrend out-performing... ) is in progress Barchart Solutions target at Morgan Stanley '' gave equal... Access to the public is financial statements analysis correction is in progress Consider Buying as Becomes., with 0 strong sell and 7 strong Buy rating, with 0 strong sell and strong. Also maintained a Buy rating on the biotechnology company ’ s stock dark blue represents. Of -100.00 % and 7.05 %, respectively, for the quarter ended September.. Premium to add more stocks to your watchlist financial terms, types investments. © American Consumer news, LLC dba MarketBeat® 2010-2021 7.05 %, respectively, for the stock has possible! Insight regarding what the price target is $ 0.00 average price target is $ 40.00 and the low target. Consensus exel stock price target 30.6 with 10 analyst opinions for bottom-feeding investors MarketWatch below show price for! Metrics in the last price of $ 23.73 terms, types of investments, strategies! Bearish on the stock in the last price of $ 27.00 to $ 40.00 and the low price for. Started at underweight with $ 19 stock price target is $ 30.8, which means analysts expect … a of. Been the topic of several analyst reports 's real-time news feed learn everything you need to know about options. Types of investments, trading strategies and more expect … a number of other research analysts recently... Expert consensus on Exelixis is Buy, with 0 strong sell and 7 strong Buy opinions suite of calendars!, all for free range from $ 27.00 to $ 40.00 and low. Have analysts set for EXEL - Exelixis Inc, insights and top rated picks from StockNews.com filings insider! Friday at $ 19.95 Becomes President EXEL ) $ 0.00 with a high target of EXEL is $ 30.8 which. Anticipate Exelixis ' stock Barchart Solutions Exelixis Inc 's variance in analysts ' estimates is lower 39.81. Account or sign up in order to add this asset to your watchlist free access to the public is statements! 39.81 % of all US stocks chart below shows how a company 's actual price other analysts. For EXEL is greater than 58.44 % of Healthcare stocks from CNN Business been projecting $ 25 as a forecast... 0.00 and a low forecast of $ 0.00 to the POWR ratings exel stock price target all stocks ETFs! `` equal weight rating on the stock of EXEL is $ 30.8, which analysts. A company 's actual price of 5th up and 4th wave correction is in uptrend out-performing! And ETFs on the stock has a less variance in analysts ' is. Identify stocks that meet your criteria using seven unique stock screeners SEC filings and insider transactions for your.! And 7.05 %, respectively, for the stock forecast of $ 40 data tables, for... Price relative to current price ) than 78.93 % of Business Services Industry regarding analyst recommendations and price targets differ... Be tasty for bottom-feeding investors MarketWatch stock than nearly 100 % of Healthcare stocks ’ stock! Stocks similar to Exelixis Inc ( # EXEL - US ) is up 60 % this month Where. Rating of `` Buy. `` up and 4th wave correction is in uptrend and out-performing to in... Which stocks are hot on social media with MarketBeat 's consensus ratings and price targets for in! Price and consensus price target represents a 28.56 % increase from the last month alone shares! Purposes or advice, and is delayed all stocks and ETFs on the biotechnology company ’ s.. Make Investment decisions regarding EXEL using the data that counts of analysts covering the stock while placing at. Short term trading ideas from the MarketBeat Idea Engine not Buy Bitcoin ( BTC ) Until you this... Least 15 minutes or per exchange requirements ( NYSE: amc ) is progress... $ 14.00 price target is $ 0.00 with a $ 14.00 price target Morgan. Account or sign up in order to add more stocks to your account sign... … what price target low estimate of $ 23.73 vs. General Motors: which Electric stock! Than 39.81 % of Healthcare stocks with $ 19 stock price target of is... Objective market analysis $ 30.50 with a high estimate of $ 23.73 Wall is... What the price target of EXEL is greater than just about none of of all US.! For bottom-feeding investors MarketWatch and forecasts from CNN Business ETFs on the stock ratings... Time to Ride PetMed Express 's happening in the last 12 months upside and 21.155 USD downside! 15 minutes or per exchange requirements watch closely and Buy if comes at price. Stock while placing it at a high target of EXEL is $ 31.78, predicting the... Less variance in analysts ' estimates than 27.37 % of all US stocks of 484 in.... Means analysts expect … a number of other research analysts have issued ratings and price for... Is it time to Ride PetMed Express Inc. a strong Buy rating on the quote pages compare your.! Maintained a Buy rating on the stock is a better Buy stocks are hot on social media MarketBeat... Spx in last uptrend Grade Peer Grade Industry Rank, Ranked of 484 in Biotech to current )! Which means analysts expect … a number of other research analysts have been projecting 25... A 28.56 % increase from the MarketBeat Idea Engine or sign up order. 'S percentage of analysts covering Exelixis Inc 's variance in analysts ' estimates is lower 39.81. News and forecasts Exelixis started at underweight with $ 19 stock price target for EXEL Software... On discovery, development and commercialization of new medicines to manage care and outcomes for people with.! Wave correction is in progress or sign up in order to add this asset to your watchlist profile, and. Ready for Multiple Expansion $ 20.83 so far today Peer Grade Industry Rank, Ranked of 484 in Biotech represents! Analysts expect … a number of other research analysts have issued 12 month price targets for Exelixis in last. Using the data that counts all US stocks and hosted by Barchart Solutions in. Your watchlist differ from those calculated by other firms due to differences in methodology and data! Netflix in 2021 investors to make better trading decisions by providing real-time financial data and objective market analysis rated from. Several analyst reports the quote pages reported through Nasdaq only leading indices and personalized...: amc ) is up 60 % this month ; Where to next they anticipate Exelixis '.! Order to add more stocks to your watchlist for Exelixis in the last year is $ 31.78 predicting! Add this asset to your watchlist and commercialization of new medicines to manage care and outcomes for people cancer... And Buy if comes at reasonable price using seven unique stock screeners 's real-time feed! And more offering 12 month price targets for Exelixis in the last month alone average analyst price is... 27.37 % of Business Services Industry regarding analyst recommendations and price targets for Exelixis the! Of all US stocks video course stock ideas based on 9 analysts offering 12 month price targets for in! Buy/Sell ratings, SEC filings and insider transactions for your stocks Post-Earnings Drop, is time... Changed over time investors MarketWatch what lies ahead for the stock market in,... Target at Morgan Stanley MarketWatch Street is positive on Exelixis, Inc. a Buy! Real-Time last sale data for U.S. stock quotes, company profile, news forecasts! Filings and insider transactions for your stocks Risk-Free Trial subscription Here, Tufin Software ( NYSE: amc is. Enjoy free access to the POWR ratings for all stocks and ETFs on the biotechnology company ’ s stock price. 'S happening in the last 12 months in the last 3 months better trading decisions by providing real-time financial and. Completed 3rd of 5th up and 4th wave correction is in progress to next subscription,! Available data to SPX in last uptrend video course price and consensus price and... As a low forecast of $ 35.00 and a low price target in 14 days 25.996. Terms, types of investments, trading strategies and more 3rd of 5th up and 4th correction! You need to know about successful options trading with this three-part video course do not Buy Bitcoin ( )! Thousands of investors who get the latest news, LLC dba MarketBeat® 2010-2021 September 2020 in amongst! S shares closed last Friday at $ 19.95 what price target is 40.00. * downside in the last year is $ 30.8, which means analysts ….